BackBioceres Crop Solutions Overview

Bioceres Crop Solutions Long-Term Investments

Latest long-term investments for BIOX: $66M.

Get informed when a big investor buys or sells

+ Follow
Long-Term Investments
$66.00M
67.63% YoYΔ $26.63M vs prior year quarter

Peer trimmed avg / median

Loading

Bioceres Crop Solutions Long-Term Investments History

Loading

Bioceres Crop Solutions vs. peers: Long-Term Investments Comparison

Loading

Bioceres Crop Solutions Long-Term Investments Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Bioceres Crop Solutions (BIOX) FAQ

Bioceres Crop Solutions (BIOX) currently reports a long-term investments of $66M as of June 2026. That compares with $39M in the prior-year period — up 67.6% year over year. Use the charts on this page to explore Bioceres Crop Solutions's long-term investments history and peer comparisons.

Bioceres Crop Solutions's long-term investments increased from $39M to $66M — a 67.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bioceres Crop Solutions reported $66M in long-term investments as of June 2026. That compares with $39M in the prior-year period — up 67.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term investments of $66M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bioceres Crop Solutions, and consider following BIOX for alerts when major investors trade the stock.

Bioceres Crop Solutions is classified in the Industrials sector. On long-term investments, it currently shows $66M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing BIOX with unrelated industries.